Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orotidine 5'-monophosphate trisodium, a pyrimidine nucleotide, is synthesized through the de novo DNA synthesis pathway by various microorganisms, including M. tuberculosis, S. cerevisiae, S. typhimurium, and P. falciparum. The compound's production involves orotate phosphoribosyltransferase (OPRT)-catalyzed reactions using phosphoribosyl pyrophosphate (PRPP) and orotic acid (OA) as substrates [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Orotidine 5'-monophosphate trisodium, a pyrimidine nucleotide, is synthesized through the de novo DNA synthesis pathway by various microorganisms, including M. tuberculosis, S. cerevisiae, S. typhimurium, and P. falciparum. The compound's production involves orotate phosphoribosyltransferase (OPRT)-catalyzed reactions using phosphoribosyl pyrophosphate (PRPP) and orotic acid (OA) as substrates [1]. |
Molecular Weight | 434.14 |
Formula | C10H10N2Na3O11P |
CAS No. | 68244-58-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orotidine 5′-monophosphate trisodium 68244-58-6 inhibitor inhibit